Laserfiche WebLink
Sub -Section 44. MEDICAL REVIEW OFFICER <br />RESPONSIBILITIES (a) The Medical Review Officer shall: <br />(1) Maintain confidentiality on all levels. <br />(2) Review and verify a positive test. <br />(3) Notify a tested employee of a positive test. <br />(4) Provide the employee an opportunity to explain a positive test. <br />(5) If an employee has appropriate documentation for use of prohibited drug <br />and the MRO determines legitimate use, the employee will continue to be <br />classified as current with the Program. <br />(6) Review employee's medical records made available to him. <br />(7) Notify the designated contractor representative when an employee is <br />ineligible under the Program. <br />(8) Advise the employee of his right to request a second test of the split <br />sample. <br />(9) Process request for retest of original sample. <br />(10) Participate in return to work decisions as required, noting employee's <br />ability to return to work with or without restrictions. <br />(11) Refer employees who test positive to appropriate medical evaluation <br />and make recommendations. <br />Sub -Section 15. CONSEQUENCES OF A POSITIVE DRUG OR ALCOHOL TEST <br />(a) If test is positive, the individual will be removed from the Project immediately <br />and paid for all hours worked. The individual will not be eligible for employment as <br />provided in Paragraphs (d), (e), (f) and (g) of this Section, unless regulated by <br />Department of Transportation or Nuclear Regulatory Commission regulations. <br />(b) Individuals who test positive shall have the right to secure a copy of all data <br />relating to the test procedures and results provided. These costs are to be paid by <br />the individual in advance. <br />(c) All employees must be current with the M.U. S. <br />T. Drug and Alcohol Screening Program in order to be employed on a covered <br />Project. <br />(d) First Violation of Program: An employee who tests positive for the first time <br />Adamo CHSP Section 10.0 <br />Drug -Free Workplace 15 February 2023 Issue <br />